DWT
TEVA icon

Dorsey & Whitney Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Dorsey & Whitney Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
9,709
+989
+11% +$32.9K 0.02% 559
2026
Q1 		$263K Buy
8,720
+341
+4% +$11K 0.01% 608
2025
Q4 		$262K Buy
+8,379
New +$206K 0.01% 601

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Dorsey & Whitney Trust's TEVA Position: Q2 2026 in Review

Dorsey & Whitney Trust increased its Teva Pharmaceuticals (TEVA) stake by 11% in Q2 2026, buying an estimated $32.9K and bringing the position to 9,709 shares worth $329K. The position accounts for 0.02% of the portfolio, ranked #559.

Dorsey & Whitney Trust first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Dorsey & Whitney Trust held 9,709 shares of Teva Pharmaceuticals worth $329K as of Q2 2026.
  • Dorsey & Whitney Trust bought 989 Teva Pharmaceuticals shares in Q2 2026, an estimated $32.9K.
  • Teva Pharmaceuticals made up 0.02% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #559 holding.
  • Dorsey & Whitney Trust first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.